Articles de recherche

Découvrez nos prochaines rencontres scientifiques et activités éducatives axées sur la promotion de la collaboration, le partage de nouvelles données probantes et le renforcement des meilleures pratiques dans le traitement des patients atteints de troubles cardiovasculaires liés au cancer.

Heart remodeling induced by adjuvant trastuzumab-containing chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2: a prospective study.

Auteurs :

Piotrowski G, Gawor R, Bourge RC, Stasiak A, Potemski P, Gawor Z, Nanda NC, Banach M.

Publication :

Pharmacological Research

Date :

2013 Dec

Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology.

Auteurs :

Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M.

Publication :

Mayo Clinic Proceedings

Date :

2014 Sep

Concomitant low-dose doxorubicin treatment and exercise.

Auteurs :

Sturgeon K, Schadler K, Muthukumaran G, Ding D, Bajulaiye A, Thomas NJ, Ferrari V, Ryeom S, Libonati JR.

Publication :

American Journal of Physiology Regulatory, Integrative and Comparative Physiology

Date :

2014 Sep 15

Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin.

Auteurs :

Zhu H, Luo P, Fu Y, Wang J, Dai J, Shao J, Yang X, Chang L, Weng Q, Yang B, He Q.

Publication :

Oncotarget

Date :

2014 Sep 5

Evaluation of cardiotoxicity via speckle-tracking echocardiography in patients treated with anthracyclines.

Auteurs :

Dogru A, Cabuk D, Sahin T, Dolasik I, Temiz S, Uygun K.

Publication :

Onkologie

Date :

Epub 2013 Nov 20

Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer.

Auteurs :

Florescu M, Magda LS, Enescu OA, Jinga D, Vinereanu D.

Publication :

Journal of the American Society of Echocardiography

Date :

2014 Jan

Editorial: Targeting Neuregulin1 and HER Receptor Tyrosine Kinases for Therapy of Breast Cancer and Heart Failure.

Auteurs :

Yan X.

Publication :

Current Pharmaceutical Design

Date :

2014

Hypertension induced by chemotherapeutic and immunosuppresive agents: A new challenge.

Auteurs :

Abi Aad S, Pierce M, Barmaimon G, Farhat FS, Benjo A, Mouhayar E.

Publication :

Critical Reviews in Oncology and Hematology

Date :

2014 Aug 27

Cardiotoxicity: Trastuzumab and cancer survivors.

Auteurs :

Patanè S.

Publication :

International Journal of Cardiology

Date :

2014 Aug 26

Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities.

Auteurs :

Shelburne N, Adhikari B, Brell J, Davis M, Desvigne-Nickens P, Freedman A, Minasian L, Force T, Remick SC.

Publication :

Journal of the National Cancer Institute

Date :

2014 Sep 10